Pfizer (PFE)
26.39
+0.52 (2.01%)
Pfizer is a global biopharmaceutical company that develops and manufactures innovative medicines and vaccines to improve health outcomes for people around the world
Renowned for its extensive research and development efforts, Pfizer focuses on various therapeutic areas including vaccines, oncology, immunology, cardiology, endocrinology, and rare diseases. The company is committed to addressing significant health challenges through the discovery of new treatments, leveraging cutting-edge science and technology. Pfizer also emphasizes partnerships and collaborations to expand its capabilities and enhance access to healthcare solutions.
![](https://g.foolcdn.com/editorial/images/806456/what-does-masayoshi-son-want.jpg)
The man behind SoftBank has now teamed up with OpenAI to invest up to $500 billion in American AI infrastructure over the next four years.
Via The Motley Fool · February 5, 2025
![](https://news-assets.stockstory.org/cover-images/eli-lilly-cover-image-3d82148895e3_2025-02-04-094122_uhvj.jpeg)
Global pharmaceutical company Eli Lilly (NYSELLY)
will be reporting results tomorrow morning. Here’s what to expect.
Via StockStory · February 5, 2025
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
PFE earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 4, 2025
![](https://cdn.content.foolcdn.com/images/1umn9qeh/production/be9e0cd38819153b58a6a5e40879d794ec76c1ff-1024x652.jpg)
Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.
Via The Motley Fool · February 4, 2025
![](https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/pfizer_logo_resized_e9b1e7b6be.jpg)
Under its restructuring program, Pfizer said it remains on track to deliver $4.5 billion in cost savings by the end of 2025.
Via Stocktwits · February 4, 2025
![](https://g.foolcdn.com/editorial/images/806143/person-holding-cash-bills-money-hundred-dollar-fifty-dividend-income-invest-retire-spend-getty.jpg)
These sensational income stocks -- sporting an average yield of 6.15% -- can fatten investors' pocketbooks for a long time to come.
Via The Motley Fool · February 4, 2025
![](https://www.chartmill.com/images/uploads/CM_Most_Active_Stocks_Small_free_fec0650b7f.webp)
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via Chartmill · February 4, 2025
![](https://news-assets.stockstory.org/cover-images/pfizer-cover-image-e2d5a6b69a6d_2024-12-17-092451_kbmj.jpeg)
Global pharmaceutical company Pfizer (NYSEPFE) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.63 per share was 37.2% above analysts’ consensus estimates.
Via StockStory · February 4, 2025
![](https://www.investors.com/wp-content/uploads/2025/02/Stock-RFKjr-01-shutt.jpg)
RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.
Via Investor's Business Daily · February 4, 2025
![](https://www.investors.com/wp-content/uploads/2017/10/stock-Pfizer-01-shutter.jpg)
Pfizer stock rose moderately early Tuesday on the back of its quarterly beat.
Via Investor's Business Daily · February 4, 2025
Pfizer Inc. reported a strong performance for the fourth quarter of 2024, with revenues reaching $17.8 billion.
Via Talk Markets · February 4, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/Pfizer-shutterstock2_2.jpeg?width=1200&height=800&fit=crop)
Pfizer Inc. (NYSEPFE) shares are trading lower Tuesday after the Senate Finance Committee voted to advance Robert F. Kennedy Jr.'s nomination for Secretary of Health and Human Services.
Via Benzinga · February 4, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/RFK---Independent-Presidential-Candidate.jpeg?width=1200&height=800&fit=crop)
The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via Benzinga · February 4, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/wall-street-photo-by-marek-masik-on-shut.jpeg?width=1200&height=800&fit=crop)
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
Via Benzinga · February 4, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/Pfizer-shutterstock2_1.jpeg?width=1200&height=800&fit=crop)
Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.
Via Benzinga · February 4, 2025
![](/next-assets/images/schema-image-default.png)
U.S. stock futures were trading lower on Tuesday after Monday's decline as the new administration tariffs continued to spook the market.
Via Benzinga · February 4, 2025
![](https://g.foolcdn.com/editorial/images/803702/pltr-palantir-technologies-stock-market-chart.jpg)
Via The Motley Fool · February 3, 2025
![](https://investorplace.com/wp-content/uploads/2025/01/tariff-declining-graph-banner.png)
Worried about market drops and tariff news? Discover why short-term volatility shouldn’t derail your long-term investing strategy, with lessons from Amazon and other market giants. Stay focused on innovation, not fear.
Via InvestorPlace · February 3, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 4, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/Pfizer-shutterstock2_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 4, 2025
![](https://www.chartmill.com/images/uploads/CM_Most_Active_Stocks_Small_free_fec0650b7f.webp)
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · February 3, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/04/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop)
US stock futures down on Tues, focus on PepsiCo, NXP Semiconductors, Pfizer earnings. UBS reports strong Q4, EA to release after market close.
Via Benzinga · February 4, 2025